drugset / Trial / NCT00033228
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Parallel-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Infusing the vaccine directly into a lymph node may cause a stronger immune response and kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have stage IV melanoma.
Timeline
- Start
- 2002-01
- Primary completion
- 2003-03
- Completion
- 2003-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MKC1106-MT | Vaccine | 500 ug | Other |
| Subject | MKC1106-MT | Vaccine | 1000 ug | Other |
| Subject | MKC1106-MT | Vaccine | 1500 ug | Other |